Corvus Pharmaceuticals

CRVSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$821.020 M

$9.76 -7.66%

Close of 6 Nov 2026

As of 6 Nov 2026, Corvus Pharmaceuticals (CRVS) has a market capitalization of $821.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$15.3M

Loss-making

Shares outstanding

84,353,126

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#155Rigel PharmaceuticalsRIGL$848.1M
#156Syndax PharmaceuticalsSNDX$842.8M
#157Corvus PharmaceuticalsCRVS$821.0M
#158Aktis OncologyAKTS$820.9M
#159Collegium PharmaceuticalCOLL$816.5M

What if Corvus Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$335,669.96

Per share 34,392× higher

Bitcoin $1.53T

$18,162.52

Per share 1,861× higher

Apple $5.02T

$59,625.85

Per share 6,109× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Corvus Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.